Conference Coverage: ASCO 2023 – Focus on Genitourinary Malignancies (GU)
Impact of recent ASCO data on clinical practice and therapy guidance in genitourinary cancers
FACULTY MEMBERS
Joaquim Bellmunt, MD, PhD
Harvard Medical School, Boston, MA, USA
Robert Dreicer, MD, MACP, FASCO
University of Virginia Cancer Center, Charlottesville, VA, USA
Karim Fizazi, MD, PhD
Institute Gustave Roussy, Villejuif, France
Leonard G. Gomella, MD, FACS
Jefferson University Hospitals, Philadelphia, PA, USA
Thomas Powles, MD, MRCP, MBBS
Barts Cancer Institute, London, UK
Oliver Sartor, MD
Tulane Medical Center, New Orleans, LA, USA
Susan Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Scott Tagawa, MD, FACP
Weill Cornell Medical Center, New York, NY, USA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Standard and Emerging Therapies in Prostate Cancer
- Targeting DNA Repair in mCRPC
- Immunotherapies in Bladder Cancer
- Targeted Therapies in Bladder Cancer
- Clear Cell Renal Cell Carcinoma
- Non-Clear Cell Renal Cell Carcinoma
